CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities:
Net income	$ 34,800	$ 34,741
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	1,633	1,692
Non-cash stock-based expense	3,314	2,106
Loss on extinguishment of debt	0	141
Deferred income taxes	(2,328)	(62)
Equity in (earnings) losses from investments	(2,138)	159
Net (gains) losses on investment securities	(1,196)	6
Equity in losses from real estate ventures	10,721	1,893
Distributions from real estate ventures	258	70
Non-cash interest expense	562	746
Non-cash lease expense	778	835
Changes in assets and liabilities:
Receivables	2,343	10,105
Inventories	(14,607)	(8,227)
Accounts payable and accrued liabilities	949	141
Amounts due under the Master Settlement Agreement	65,152	66,911
Litigation accruals	39	294
Other assets and liabilities, net	10,048	9,231
Net cash provided by operating activities	110,328	120,782
Cash flows from investing activities:
Sale of investment securities	0	9,455
Maturities of investment securities	12,272	18,459
Purchase of investment securities	(30,025)	(18,389)
Proceeds from sale or liquidation of long-term investments	2,214	0
Purchase of long-term investments	(2,000)	0
Investments in real estate ventures	(1,883)	(2,920)
Distributions from investments in real estate ventures	10,029	0
Increase in cash surrender value of life insurance policies	(692)	(272)
Increase in restricted assets	(15)	(3)
Capital expenditures	(1,565)	(5,983)
Paydowns of investment securities	21	33
Net cash (used in) provided by investing activities	(11,644)	380
Cash flows from financing activities:
Repurchase and repayments of debt	(8)	(6,700)
Borrowings under revolving credit facility	231	87,294
Repayments on revolving credit facility	(231)	(109,329)
Dividends on common stock	(31,918)	(31,680)
Withholding of shares as payment of payroll tax liabilities in connection with restricted stock vesting and exercise of stock options	(3,405)	(3,188)
Net cash used in financing activities	(35,331)	(63,603)
Net increase in cash, cash equivalents and restricted cash	63,353	57,559
Cash, cash equivalents and restricted cash, beginning of period	270,106	250,374
Cash, cash equivalents and restricted cash, end of period	$ 333,459	$ 307,933